With regards to Glo1 as a drug target, Sharkey et al. [117] provided the first demonstration that a competitive inhibitor of Glo1 effectively inhibited the growth of PCa tumors in mice, when delivered as the diethyl ester prodrug. Here, GLO1 is linked to posterior cortical atrophy.